Severe respiratory failure as a presenting feature of an interstitial lung disease associated with anti-synthetase syndrome (ASS)

被引:11
|
作者
Piroddi, Ines Maria Grazia [1 ]
Ferraioli, Gianluca [2 ]
Barlascini, Cornelius [3 ]
Castagneto, Corrado [4 ]
Nicolini, Antonello [1 ]
机构
[1] Resp Dis Unit ASL4 Chiavarese, Via Terzi 43, I-16039 Sestri Levante, Italy
[2] Emergency & Internal Med Dept ASL4 Chiavarese, Sestri Levante, Italy
[3] Hyg & Hlth Med Unit ASL4 Chiavarese, Sestri Levante, Italy
[4] Internal Med Dept ASL4 Chiavarese, Sestri Levante, Italy
关键词
Anti-synthetase syndrome; Severe respiratory failure; Non-invasive ventilation; Interstitial lung disease;
D O I
10.1016/j.resinv.2016.01.005
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Anti-synthetase syndrome (ASS) is defined as a heterogeneous connective tissue disorder characterized by the association of an interstitial lung disease (ILD) with or without inflammatory myositis with the presence of anti-aminoacyl-tRNA-synthetase antibodies. ILD is one of the major extra-muscular manifestations of polymyositis and dermatomyositis. We report a case of a patient with dyspnea, cough, and intermittent fever as well as ILD associated ASS in the absence of muscular involvement. This patient was admitted to the emergency department with severe respiratory failure requiring non-invasive ventilation. Our patient's case demonstrates that the diagnosis of ASS may not be obvious. However, its diagnosis leads to appropriate and potentially life-saving treatment. (C) 2016 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:284 / 288
页数:5
相关论文
共 50 条
  • [1] CHARACTERISATION OF ANTI-SYNTHETASE SYNDROME (ASS), INITIALLY PRESENTING TO RESPIRATORY SERVICES AS INTERSTITIAL LUNG DISEASE (ILD) OF UNKNOWN CAUSE
    Barratt, S. L.
    Iftikar, H.
    McMillan, M.
    Edey, A.
    Adamali, H.
    Gunawardena, H.
    THORAX, 2018, 73 : A91 - A92
  • [2] Rituximab treatment in a case of anti-synthetase syndrome with severe interstitial lung disease and acute respiratory failure
    Zappa, Maria Cristina
    Trequattrini, Tiziana
    Mattioli, Francesco
    Rivitti, Rosario
    Vigliarolo, Rossana
    Marcoccia, Antonella
    D'Arcangelo, Giovanni
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2011, 6 (03) : 183 - 188
  • [3] Isolated interstitial lung disease associated with anti-synthetase syndrome
    Acharya, S.
    Meador, R.
    Plocharczyk, E.
    Tiwari, A.
    Gupta, S. S.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2022, 115 (06) : 408 - 409
  • [4] Anti-synthetase syndrome associated Interstitial Lung Disease (ASS-ILD): clinical heterogeneity and outcome
    Rathnapala, Amila
    Addala, D.
    Ng, B.
    Mahesh, S.
    David, J.
    Hoyles, R. K.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [5] Treatment of Interstitial Lung Disease Associated With Myositis and the Anti-Synthetase Syndrome
    Robert W. Hallowell
    Sonye K. Danoff
    Current Treatment Options in Rheumatology, 2018, 4 (4) : 316 - 328
  • [6] Interstitial lung disease as the first manifestation of anti-synthetase syndrome
    Pires, Mario
    Sousa, Magda
    Montez, Ana
    Araujo, Ana
    GALICIA CLINICA, 2014, 75 (01): : 28 - 30
  • [7] Use of Tacrolimus to Treat Anti-Synthetase Syndrome-Associated Interstitial Lung Disease
    Warrior, K.
    Bemiss, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] Successful baricitinib treatment of refractory anti-synthetase syndrome associated with interstitial lung disease
    Sugino, Keishi
    Ono, Hirotaka
    Saito, Mikako
    Ando, Masahiro
    Tsuboi, Eiyasu
    RESPIROLOGY CASE REPORTS, 2023, 11 (04):
  • [9] Tacrolimus rescue therapy for severe respiratory failure in the anti-synthetase syndrome
    Rigby, Amy L.
    Plit, Marshall
    Glanville, Allan R.
    RESPIROLOGY CASE REPORTS, 2014, 2 (02): : 70 - 72
  • [10] Interstitial Lung Disease in Anti-synthetase Syndrome: A Single Center Experience
    Khasawneh, M.
    Pais, F.
    Patel, D. C.
    Reddy, R.
    Manjarres, D. C. Gomez
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207